title: [Clinical applications of TRAIL in cancers. The prostate cancer example].
authors.forename: V
authors.initials: V
authors.lastname: Hesry
authors.forename: T
authors.initials: T
authors.lastname: Guillaudeux
authors.forename: J J
authors.initials: JJ
authors.lastname: Patard
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017209:Apoptosis; D051017:Apoptosis Regulatory Proteins; D006801:Humans; D008297:Male; D008562:Membrane Glycoproteins / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D053221:TNF-Related Apoptosis-Inducing Ligand; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D051017:Apoptosis Regulatory Proteins; D008562:Membrane Glycoproteins; D053221:TNF-Related Apoptosis-Inducing Ligand; C505653:TNFSF10 protein, human; D014409:Tumor Necrosis Factor-alpha